Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FCN9D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,397
Award facts
- Contract value 100% obligated
- $21,397.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,397.33 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packages). This firm fixed price delivery order, awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
The RINVOQ ER medication is a targeted therapy used in treating rheumatoid arthritis and other inflammatory conditions, consistent with AmerisourceBergen's broad portfolio of specialty pharmaceuticals supplied to the Department of Defense and federal healthcare systems. This delivery order exemplifies the company's role as a primary pharmaceutical vendor within DLA's medical supply chain, fulfilling federal medical commodity requirements on a competitive basis. The award demonstrates the company's continued capability to meet military healthcare program needs through its comprehensive global pharmaceutical support vehicle, which enables distribution of medications, vaccines, and related medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FCN9D?
SPE2DR26FCN9D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCN9D worth?
The government has obligated $21,397 on SPE2DR26FCN9D.
Is contract SPE2DR26FCN9D an order under another contract?
Yes. SPE2DR26FCN9D is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCN9D competed?
The extent of competition for SPE2DR26FCN9D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award